EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Technical Application Guide

What This Product Solves

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride; CAS 25952-53-8) is a water-soluble carbodiimide reagent designed for the activation of carboxyl groups in peptide synthesis, bioconjugation, nucleotide synthesis, and select esterification or lactonization reactions. Its primary function is to facilitate direct amide bond formation between carboxyl and primary amine groups in aqueous or mixed solvent systems. This reagent addresses key challenges in workflows that require high-efficiency coupling in water, reducing the complications of organic solvent handling and minimizing side reactions compared to less water-compatible carbodiimide reagents. By generating a short-lived O-acylisourea intermediate, EDC.HCl enables rapid and specific coupling, converting into a non-reactive urea byproduct post-reaction.

Researchers benefit from EDC.HCl when optimizing peptide assembly, bioconjugation of proteins or small molecules, or nucleotide backbone modifications. However, it should not be used for in vivo or clinical applications; there is currently no documented safety or efficacy data for such uses. For technical background, see the APExBIO product page.

Protocol Parameters

• Solubility in Water: 39 mg/mL or higher | Product specification | Ensures reagent can be directly dissolved in aqueous buffers for peptide synthesis or bioconjugation without requiring organic co-solvents. | Product dossier
• Storage Conditions: Store as solid, desiccated at -20°C | Product specification | Prevents hydrolysis and degradation, preserving reagent activity; do not store solutions long-term. | Product dossier
• Reaction Monitoring: Quantitative monitoring via spectrophotometry | Workflow recommendation | Allows real-time assessment of coupling efficiency and reagent consumption; suitable for process QC. | Product dossier
• Solution Stability: Prepare fresh solutions before use; avoid prolonged storage at room temperature | Workflow recommendation | Minimizes hydrolytic decomposition and maintains reproducibility. | Workflow recommendation
• Concentration in DMSO: ≥19.2 mg/mL | Product specification | Enables alternative solvent use for less water-soluble substrates. | Product dossier

Workflow Setup and QC Checklist

• Reagent Preparation: Dissolve EDC.HCl in water, DMSO, or ethanol immediately prior to use. Filter sterilize if required for bioconjugation with sensitive biomolecules.
• Buffer Selection: Use non-nucleophilic buffers (e.g., MES, pH 4.5–6) to avoid competing side reactions. Avoid phosphate and Tris buffers, which can react with activated intermediates.
• Substrate Compatibility: Confirm carboxyl- and amine-containing substrates are free from interfering functional groups (e.g., excess thiols or nucleophilic contaminants).
• Reaction Initiation: Add EDC.HCl last to minimize premature hydrolysis. For peptide synthesis, consider sequential addition of N-hydroxysuccinimide (NHS) if enhanced intermediate stability is desired.
• Reaction Monitoring: Use spectrophotometric or chromatographic methods to track amide formation and reagent consumption. Document all time points and confirm completion by disappearance of starting material.
• Product Isolation: Remove urea byproduct via precipitation, dialysis, or chromatography as per downstream requirements.
• QC Checkpoints: Validate product identity (e.g., by mass spectrometry or HPLC) and confirm absence of excess EDC/HCl or urea. Record batch-specific yield and purity for reproducibility tracking.

For additional technical context, the article EDC.HCl: Practical Technical Guide provides further details on workflow integration for peptide and nucleotide coupling, while Technical Workflow Guidance offers procedural advice on in vitro-only applications and quality control.

Common Failure Modes and Fixes

• Hydrolysis of Activated Intermediates: Premature hydrolysis can occur if EDC.HCl is exposed to water for extended periods prior to substrate addition. Fix: Prepare solutions immediately before use, add EDC last, and work at lower temperatures if possible.
• Low Coupling Efficiency: Suboptimal pH, buffer incompatibility, or impure substrates can reduce yield. Fix: Use validated buffer systems (MES, pH 4.5–6), confirm substrate purity, and optimize molar ratios with pilot reactions.
• Side Product Formation: Overactivation or presence of nucleophilic buffer components (e.g., Tris) can lead to undesired byproducts. Fix: Avoid nucleophilic buffers, use minimal excess of EDC.HCl, and quench reactions promptly after completion.
• Incomplete Product Recovery: Urea byproducts or excess reagent may co-purify with product. Fix: Employ appropriate purification (e.g., dialysis for bioconjugates; HPLC for peptides) and include wash steps.

Scope and Limitations

EDC.HCl is engineered for in vitro peptide synthesis, bioconjugation, nucleotide assembly, and select esterification reactions, leveraging its water solubility and efficient amide bond formation profile. It is not intended for in vivo, animal, or clinical research as neither safety nor pharmacokinetic data exist for these domains. Long-term solution storage is discouraged due to hydrolytic instability; always prepare fresh working solutions. The reagent is not suitable for workflows requiring persistent carbodiimide activity over extended reaction times or in biological fluids.

Conclusion

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) provides a robust, water-soluble option for controlled amide bond formation in in vitro research settings, including peptide synthesis and bioconjugation. Adherence to best practices—fresh solution preparation, validated buffer systems, and rigorous QC—will maximize reproducibility and yield. For full technical specifications and ordering, see the APExBIO product page.